64 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
their respective successors are elected and qualified, or until their earlier death, resignation or removal.
To ratify the appointment of Ernst … of three years and until their respective successors are elected and qualified, or until their earlier death, resignation or removal
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
. If a Participant ceases to be a Service Provider, other than upon the Participant’s termination as the result of the Participant’s death or Disability … a Service Provider, the Option may be exercised within six (6) months following the Participant’s death, or within such longer or shorter period of time
8-K
00u ibf3epmm
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
EX-10.1
g73fuj 39
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
9flh9hz
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.2
q6yapckd 1mqnv
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.3
j8ieda3ashizli2p
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-3.1
jpo77jow8aub7 ghg18
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
DEFC14A
1qgcaez1s1n7s
11 Apr 22
Proxy in contested solicitation
8:36am
PREC14A
8e5d0mxuc jer55kyslq
8 Apr 22
Preliminary proxy with contested solicitation
4:21pm